Skip to main content

Consensus statement on depression, anxiety, and cardiovascular disease.

Publication ,  Journal Article
Ballenger, JC; Davidson, JR; Lecrubier, Y; Nutt, DJ; Roose, SP; Sheps, DS; International Consensus Group on Depression and Anxiety
Published in: J Clin Psychiatry
2001

Duke Scholars

Published In

J Clin Psychiatry

ISSN

0160-6689

Publication Date

2001

Volume

62 Suppl 8

Start / End Page

24 / 27

Location

United States

Related Subject Headings

  • Selective Serotonin Reuptake Inhibitors
  • Risk Factors
  • Psychotherapeutic Processes
  • Psychiatry
  • Practice Guidelines as Topic
  • Humans
  • Depressive Disorder
  • Comorbidity
  • Cognitive Behavioral Therapy
  • Cardiovascular Diseases
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ballenger, J. C., Davidson, J. R., Lecrubier, Y., Nutt, D. J., Roose, S. P., Sheps, D. S., & International Consensus Group on Depression and Anxiety. (2001). Consensus statement on depression, anxiety, and cardiovascular disease. J Clin Psychiatry, 62 Suppl 8, 24–27.
Ballenger, J. C., J. R. Davidson, Y. Lecrubier, D. J. Nutt, S. P. Roose, D. S. Sheps, and International Consensus Group on Depression and Anxiety. “Consensus statement on depression, anxiety, and cardiovascular disease.J Clin Psychiatry 62 Suppl 8 (2001): 24–27.
Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Roose SP, Sheps DS, et al. Consensus statement on depression, anxiety, and cardiovascular disease. J Clin Psychiatry. 2001;62 Suppl 8:24–7.
Ballenger, J. C., et al. “Consensus statement on depression, anxiety, and cardiovascular disease.J Clin Psychiatry, vol. 62 Suppl 8, 2001, pp. 24–27.
Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Roose SP, Sheps DS, International Consensus Group on Depression and Anxiety. Consensus statement on depression, anxiety, and cardiovascular disease. J Clin Psychiatry. 2001;62 Suppl 8:24–27.

Published In

J Clin Psychiatry

ISSN

0160-6689

Publication Date

2001

Volume

62 Suppl 8

Start / End Page

24 / 27

Location

United States

Related Subject Headings

  • Selective Serotonin Reuptake Inhibitors
  • Risk Factors
  • Psychotherapeutic Processes
  • Psychiatry
  • Practice Guidelines as Topic
  • Humans
  • Depressive Disorder
  • Comorbidity
  • Cognitive Behavioral Therapy
  • Cardiovascular Diseases